Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This issue came to the fore in early 2024 when the UK MHRA issued a National Patient Safety Alert triggered by global supply issues for certain GLP-1 drugs, advising healthcare professionals to conserve existing stock for patients with Type 2 diabetes.6,7 The implementation of such measures ensures that the critical priority of patient needs continues to be met, while also avoiding patients seeking what the WHO describes as falsified or substandard versions of these medicines through unregulated outlets on the internet.8 Looking to the future, demand for GLP-1 drugs is expected to remain high as healthcare systems look to manage obesity and diabetes among an ageing population
Pang et al
Switching from a compounded to a brand-name GLP-1
Protein intake is essential to prevent muscle loss and maintain satiety while on GLP-1 medications (Locatelli et al., 2024)
GLP-1 (glucagon-like peptide-1) is a hormone that regulates blood sugar and appetite
Wegovy may cause low blood sugar in people with type 2 diabetes
US$ 29.88
US$ 28.50
US$ 26.54
US$ 26.86
